4d Molecular Therapeutics Inc Asset Turnover Ratio (FDMT), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
4d Molecular Therapeutics Inc   (NASDAQ: FDMT)
 

4d Molecular Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

4d Molecular Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.18 in the second quarter (Jun 30 2026)

Within sector 38 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 2907, from total ranking in the first quarter 2026 at 3393.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FDMT Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 18.93 % -0.55 % 4.74 % -27.57 % -22.62 %
Y / Y Revenue Change 25106.67 % 21664.29 % 8508900 % 2900 % 200 %
Asset Turnover Ratio (TTM) 0.18 0.18 0.17 0 0
FDMT's Total Ranking # 2907 # 3393 # 4032 # 4115 # 4154
Seq. Asset Change 9.82 % -9.49 % 33.66 % -10.48 % -8.16 %
Seq. Revenue Change 24.09 % -96.42 % 94444.44 % 500 % 7.14 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 39
Healthcare Sector # 437
Overall Market # 2907

Asset Turnover Ratio Statistics
High Average Low
0.18 0.05 0
(Jun 30 2026)   (Sep 30 2024)




FDMT Company Profile • Back to FDMT Efficiency Comparisons • Compare FDMT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Syndax Pharmaceuticals Inc   0.45 $ 252.004  Millions$ 564.455  Millions
Arvinas Inc   0.44 $ 316.700  Millions$ 721.200  Millions
Picard Medical Inc   0.42 $ 5.983  Millions$ 14.114  Millions
Xilio Therapeutics Inc   0.42 $ 64.092  Millions$ 151.530  Millions
Dyadic International Inc   0.42 $ 3.802  Millions$ 8.991  Millions
Surgery Partners Inc   0.42 $ 3,366.300  Millions$ 8,039.525  Millions
Regenxbio Inc   0.41 $ 174.482  Millions$ 426.687  Millions
Medtronic Plc  0.41 $ 37,542.000  Millions$ 92,340.000  Millions
Viatris Inc   0.40 $ 14,737.300  Millions$ 36,748.175  Millions
Immunocore Holdings Plc  0.40 $ 430.775  Millions$ 1,090.322  Millions
Quanterix Corporation  0.39 $ 152.716  Millions$ 387.301  Millions
Bausch and Lomb Corp  0.38 $ 5,324.000  Millions$ 13,873.250  Millions
Biomarin Pharmaceutical Inc  0.38 $ 3,406.614  Millions$ 8,880.837  Millions
Veracyte Inc   0.38 $ 544.735  Millions$ 1,424.143  Millions
Beta Bionics Inc   0.38 $ 119.513  Millions$ 313.898  Millions
Ars Pharmaceuticals Inc   0.38 $ 116.927  Millions$ 309.380  Millions
Arrowhead Pharmaceuticals Inc   0.37 $ 669.495  Millions$ 1,787.717  Millions
Sotera Health Company  0.37 $ 1,215.925  Millions$ 3,248.010  Millions
Intelligent Bio Solutions Inc   0.37 $ 4.215  Millions$ 11.273  Millions
Gossamer Bio Inc   0.36 $ 53.286  Millions$ 146.709  Millions
Aquestive Therapeutics Inc   0.36 $ 54.087  Millions$ 149.303  Millions
Ionis Pharmaceuticals Inc   0.36 $ 1,169.419  Millions$ 3,238.360  Millions
Bionexus Gene Lab Corp   0.36 $ 3.127  Millions$ 8.660  Millions
Sensus Healthcare Inc   0.36 $ 18.294  Millions$ 51.035  Millions
Innovative Eyewear Inc   0.36 $ 3.412  Millions$ 9.567  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,105.000  Millions$ 40,125.250  Millions
Cardiff Lexington Corporation  0.35 $ 10.213  Millions$ 29.417  Millions
Invo Fertility Inc   0.34 $ 7.531  Millions$ 22.386  Millions
Pelthos Therapeutics Inc   0.32 $ 43.304  Millions$ 134.891  Millions
Volitionrx Limited  0.32 $ 2.458  Millions$ 7.672  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.